Philip Morris To Buy UK’s Vectura In ‘Beyond Nicotine’ Push
Marlboro cigarettes maker Philip Morris International agreed on Friday to buy British drugmaker Vectura for £1.05 billions ($1.44 billion) to bolster its portfolio of products that are free from tobacco or nicotine.
The cigarette maker unveiled its ‘beyond nicotine’ strategy in February, as it expects more people to quit smoking in the coming years amid health concerns and regulatory crackdowns.
The US-based company has plans for Vectura to operate as an independent unit at the centre of its inhaled therapeutics business, seeking to use its expertise in inhalation and aerosolisation in areas such as respiratory drug delivery.
ESM
Related news
Philip Morris to build nicotine pouch production facility in Aurora
Philip Morris International announced plans last week to invest $600…
Read more >
One in four adults wants to quit smoking due to price increases
According to the results of a recent research in England,…
Read more >
This is how Hungarians feel about smoking culture
More and more people are using heated tobacco products, so…
Read more >Related news
A new office responsible for food safety and retail trade can be established under the leadership of Márton Nagy
A new top organization called the National Trade Office could…
Read more >
K&H: Almost two-thirds of businesses are planning development
The majority of domestic micro, small and medium-sized enterprises, 61…
Read more >
KSH: industrial production fell by 8.2 percent in June
In June 2024, the volume of industrial production was 8.2…
Read more >
